PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma
Cited by 46
Related Papers
A peptidic inhibitor for PD-1 palmitoylation targets its expression and functions
|RSC Chemical Biology|2020|70
IL-17 induces macrophages to M2-like phenotype via NF-κB
|Cancer Management and Research|2018|68